- Home
- FRBA vs SLP Comparison
FRBA vs SLP Comparison
Compare FRBA & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FRBA | SLP |
|---|---|---|
| Founded | 2007 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | EDP Services |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 377.6M | 322.4M |
| IPO Year | N/A | 1997 |
Fundamental Metrics
Financial Performance| Metric | FRBA | SLP |
|---|---|---|
| Price | $18.07 | $18.53 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 7 |
| Target Price | $19.00 | ★ $27.25 |
| AVG Volume (30 Days) | 66.5K | ★ 431.2K |
| Earning Date | 01-22-2026 | 01-08-2026 |
| Dividend Yield | ★ 1.35% | N/A |
| EPS Growth | ★ 3.13 | N/A |
| EPS | ★ 1.65 | N/A |
| Revenue | ★ $135,175,000.00 | $79,179,000.00 |
| Revenue This Year | $15.53 | $2.02 |
| Revenue Next Year | $5.97 | $6.92 |
| P/E Ratio | $10.79 | ★ N/A |
| Revenue Growth | 9.51 | ★ 13.09 |
| 52 Week Low | $12.74 | $12.39 |
| 52 Week High | $17.91 | $37.67 |
Technical Indicators
Market Signals| Indicator | FRBA | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 79.98 | 51.59 |
| Support Level | $15.93 | $19.11 |
| Resistance Level | $16.34 | $19.58 |
| Average True Range (ATR) | 0.38 | 0.94 |
| MACD | 0.23 | -0.13 |
| Stochastic Oscillator | 99.21 | 47.12 |
Price Performance
Historical ComparisonAbout FRBA First Bank
First Bank is a full-service commercial bank, with target businesses from individuals, businesses, and governmental entities located in service regions throughout New Jersey and eastern Pennsylvania, with a particular focus between New York City and Philadelphia. The group focuses on traditional deposit and loan products with businesses and individuals living and working in markets as the source of businesses. Its services are Business Banking; Personal banking; Digital Banking; and Lending.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.